The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech BreakthroughsInvestorPlace • 01/25/24
Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen's Cell-Free DNA Production TechnologyBusiness Wire • 01/24/24
GSK (GSK) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 01/17/24
GSK and AstraZeneca: A leading investment bank gives its verdict with an upgrade and a downgradeProactive Investors • 01/16/24
iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must WatchSeeking Alpha • 01/10/24